DCGI approved Themis Medicare’s VIRALEX effective against COVID-19, viral respiratory infections - ETHealthWorld

The drug has been approved for treatment of influenza and other acute viral respiratory infections (AVRI) including COVID-19, mucocutaneous herpes, genital wart and subacute sclerosing panencephalitis (SSPE) by DCGI.

Mumbai: Themis Medicares VIRALEX is an effective and safe drug for management of mild to moderate COVID-19 and other acute viral respiratory infections.VIRALEX- Inosine Pranobex is the new option for… [+1862 chars]

full article...